In contrast, the levels of phosphorylated p38MAPK and AKT decreased but ERK phosphorylation remained unchanged in both nimbolide-treated bladder cancer cell lines (Figure 4). The gene discussed is AKT1; the disease is urinary bladder carcinoma.